论文部分内容阅读
目的探讨阿奇霉素序贯疗法用于治疗支原体肺炎的效果,为临床提供参考。方法选取116例肺炎支原体感染的患者,随机分为对照组和治疗组,两组均给予常规治疗,同时对照组使用罗红霉素颗粒进行治疗,治疗组用阿奇霉素序贯疗法进行治疗,观察两组患者主要生理指标变化、临床疗效及不良反应等。结果经治疗后,对照组临床总有效率为72.4%,治疗组为94.8%,两组比较差异有统计学意义(P<0.05);治疗组在体温复常时间、咳嗽消失时间、症状好转时间及住院时间较对照组明显缩短,差异有统计学意义(P<0.05);两组患者均未出现其他严重的不良反应。结论采用阿奇霉素序贯疗法用于治疗支原体肺炎,可显著改善临床症状,缩短住院时间,提高临床疗效,且安全性较好,具有较大的临床借鉴意义。
Objective To investigate the effect of sequential therapy of azithromycin in the treatment of mycoplasma pneumonia and provide a reference for clinical practice. Methods One hundred and sixteen patients with Mycoplasma pneumoniae infection were randomly divided into control group and treatment group. Both groups were given routine treatment, while the control group was treated with roxithromycin granules. The treatment group was treated with azithromycin sequential therapy. Group of patients with major physiological changes, clinical efficacy and adverse reactions. Results After treatment, the total clinical effective rate was 72.4% in the control group and 94.8% in the treatment group, with significant difference between the two groups (P <0.05). The treatment group showed no significant difference in body temperature normalization time, cough disappearance time, And hospitalization time was significantly shorter than the control group, the difference was statistically significant (P <0.05); no other serious adverse reactions in both groups. Conclusion Sequential azithromycin therapy for the treatment of mycoplasma pneumonia can significantly improve clinical symptoms, shorten the hospital stay and improve clinical efficacy, and safety is good, with great clinical significance.